CORRELATION BETWEEN MRI-BASED BRAIN VOLUME CHANGES AND COGNITIVE DECLINE IN PATIENTS WITH MILD COGNITIVE IMPAIRMENT: A PROSPECTIVE OBSERVATIONAL STUDY.

Karishma Khushalrao  Surpam

doi:10.51168/sjhrafrica.v6i3.1769

Authors

Karishma Khushalrao Surpam Assistant Professor Department Of Radiodiagnosis, Late Smt. Indira Gandhi Memorial Government Medical College and Hospital , Kanker, Chattisgarh, India

DOI:

https://doi.org/10.51168/sjhrafrica.v6i3.1769

Keywords:

Mild Cognitive Impairment, Cognitive Decline, MRI Volumetry, Hippocampal Volume, Entorhinal Cortex, MMSE, Brain Atrophy, Neuroimaging Biomarkers

Abstract

Background
Mild Cognitive Impairment (MCI) is an intermediate stage between normal cognitive aging and dementia, characterized by subtle cognitive decline. MRI-based brain volumetry, particularly of the hippocampus and entorhinal cortex, has been proposed as a potential biomarker for predicting cognitive deterioration. This study aimed to assess the relationship between structural brain volume changes and cognitive decline among patients diagnosed with Mild Cognitive Impairment (MCI).

Methods
A prospective cohort of 100 patients diagnosed with MCI (mean age 68.5 ± 6.7 years; 54% male) was enrolled. Baseline cognitive function was assessed using the Mini-Mental State Examination (MMSE), and MRI-based volumetric analysis of the hippocampus and entorhinal cortex was conducted. Participants were followed for 12 months, with cognitive status reassessed. Pearson correlation and multiple linear regression analyses were performed to examine associations between brain volume and cognitive performance.

Results
Baseline MMSE scores averaged 26.2 ± 1.8. Pearson correlation revealed a significant positive association between hippocampal volume (r = 0.58, p < 0.001) and entorhinal cortex volume (r = 0.51, p < 0.001) with MMSE scores. Participants with cognitive decline (n = 40) exhibited significantly greater hippocampal volume reduction (5.2% ± 1.1%) compared to stable participants (2.1% ± 0.9%; p < 0.001). Multiple regression analysis identified hippocampal (β = 0.43, p < 0.001) and entorhinal cortex volumes (β = 0.37, p = 0.002) as independent predictors of cognitive performance (adjusted R² = 0.42, p < 0.001).

Conclusions
MRI-based volumetric reductions in the hippocampus and entorhinal cortex are significantly correlated with cognitive decline in MCI patients, suggesting their potential as predictive biomarkers for disease progression.

Recommendations

Recommend integrating MRI-based hippocampal and entorhinal cortex volumetry into routine MCI assessments for early detection and intervention.

References

Ries ML, Carlsson CM, Rowley HA, Sager MA, Gleason CE, Asthana S, Johnson SC. Magnetic resonance imaging characterization of brain structure and function in mild cognitive impairment: a review. J Am Geriatr Soc. 2008 May;56(5):920-34. doi: 10.1111j.1532-5415.2008.01684.x. Epub 2008 Apr 9. PMID: 18410325; PMCID: PMC2668820.

Wu A, Sharrett AR, Gottesman RF, Power MC, Mosley TH Jr, Jack CR Jr, Knopman DS, Windham BG, Gross AL, Coresh J. Association of Brain Magnetic Resonance Imaging Signs With Cognitive Outcomes in Persons With Nonimpaired Cognition and Mild Cognitive Impairment. JAMA Netw Open. 2019 May 3;2(5):e193359. doi: 10.1001/jamanetworkopen.2019.3359. PMID: 31074810; PMCID: PMC6512274.

Barekatain M, Askarpour H, Zahedian F, Walterfang M, Velakoulis D, Maracy MR, Jazi MH. The relationship between regional brain volumes and the extent of coronary artery disease in mild cognitive impairment. J Res Med Sci. 2014 Aug;19(8):739-45. PMID: 25422659; PMCID: PMC4235094.

Reas ET, Hagler DJ Jr, White NS, Kuperman JM, Bartsch H, Wierenga CE, Galasko D, Brewer JB, Dale AM, McEvoy LK. Microstructural brain changes track cognitive decline in mild cognitive impairment. Neuroimage Clin. 2018;20:883-891. doi: 10.1016/j.nicl.2018.09.027. Epub 2018 Sep 26. PMID: 30290303; PMCID: PMC6171091.

Landau SM, Harvey D, Madison CM, Reiman EM, Foster NL, Aisen PS, Petersen RC, Shaw LM, Trojanowski JQ, Jack CR Jr, Weiner MW, Jagust WJ; Alzheimer's Disease Neuroimaging Initiative. Comparing predictors of conversion and decline in mild cognitive impairment. Neurology. 2010 Jul 20;75(3):230-8. doi: 10.1212/WNL.0b013e3181e8e8b8. Epub 2010 Jun 30. PMID: 20592257; PMCID: PMC2906178.

Zhou L, Yang W, Liu Y, Li J, Zhao M, Liu G, Zhang J. Correlations between cognitive reserve, gray matter, and cerebrospinal fluid volume in healthy elders and mild cognitive impairment patients. Front Neurol. 2024 Mar 1;15:1355546. doi: 10.3389/fneur.2024.1355546. PMID: 38497043; PMCID: PMC10941649.

Zhang N, Song X, Zhang Y; Alzheimer's Disease Neuroimaging Initiative. Combining structural brain changes improves the prediction of Alzheimer's disease and mild cognitive impairment. Dement Geriatr Cogn Disord. 2012;33(5):318-26. doi: 10.1159/000339364. Epub 2012 Jul 2. PMID: 22759808; PMCID: PMC3490129.

Arlt S, Buchert R, Spies L, Eichenlaub M, Lehmbeck JT, Jahn H. Association between fully automated MRI-based volumetry of different brain regions and neuropsychological test performance in patients with amnestic mild cognitive impairment and Alzheimer's disease. Eur Arch Psychiatry Clin Neurosci. 2013 Jun;263(4):335-44. doi: 10.1007/s00406-012-0350-7. Epub 2012 Sep 1. PMID: 22940716.

Mungas D, Reed BR, Jagust WJ, DeCarli C, Mack WJ, Kramer JH, Weiner MW, Schuff N, Chui HC. Volumetric MRI predicts rate of cognitive decline related to AD and cerebrovascular disease. Neurology. 2002 Sep 24;59(6):867-73. doi: 10.1212/wnl.59.6.867. PMID: 12297568; PMCID: PMC1820873.

Kantarci K, Weigand SD, Przybelski SA, Preboske GM, Pankratz VS, Vemuri P, Senjem ML, Murphy MC, Gunter JL, Machulda MM, Ivnik RJ, Roberts RO, Boeve BF, Rocca WA, Knopman DS, Petersen RC, Jack CR Jr. MRI and MRS predictors of mild cognitive impairment in a population-based sample. Neurology. 2013 Jul 9;81(2):126-33. doi: 10.1212/WNL.0b013e31829a3329. Epub 2013 Jun 12. PMID: 23761624; PMCID: PMC3770173.

Yin C, Li S, Zhao W, Feng J. Brain imaging of mild cognitive impairment and Alzheimer's disease. Neural Regen Res. 2013 Feb 15;8(5):435-44. doi: 10.3969/j.issn.1673-5374.2013.05.007. PMID: 25206685; PMCID: PMC4146132.

Amland R, Selbæk G, Brækhus A, Edwin TH, Engedal K, Knapskog AB, Olsrud ER, Persson K. Clinically feasible automated MRI volumetry of the brain as a prognostic marker in subjective and mild cognitive impairment. Front Neurol. 2024 Jul 1;15:1425502. doi: 10.3389/fneur.2024.1425502. PMID: 39011362; PMCID: PMC11248186.